UNSPSC 51192304: Ammonium chloride/potassium citrate/potassium gluconate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class TN490. This VA Drug Class (TN490) classifies this compound as belonging to the group ELECTROLYTES/MINERALS, COMBINATIONS.

UNSPSC 51192304 Ammonium chloride/potassium citrate/potassium gluconate is a Commodity code under which state and local governments procure electrolyte and chemical compounds for water treatment, medical, and pharmaceutical applications. Recent solicitations show municipal water utilities buying chemical additives for water pollution control and corrosion management, while multi-state cooperative purchasing vehicles source generic pharmaceuticals and over-the-counter products containing these and related electrolyte formulations for distribution through authorized wholesalers to state and local health and human services facilities. The issuing bodies include municipal water utilities, state departments of administration acting through cooperative purchasing alliances, and participating state and local healthcare facilities. Water treatment procurement drives unit-cost evaluation on firm pricing for estimated quarterly or annual quantities, while pharmaceutical procurement operates on wholesale distributor networks with tiered pricing models (flat price, net price windows, or WAC-minus structures) and administrative fee arrangements.

Geographic activity centers on Connecticut and the multi-state Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) footprint covering Minnesota, Oregon, and participating states. The City of Meriden posted solicitation B027-15 for sodium bisulfite chemical supply to its Water Pollution Control Facility on July 8, 2026, with bids due July 29, 2026, under an IFB with $1 million to $2 million general liability insurance requirements and performance and payment bonds. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) to establish multi-award contracts for generic pharmaceuticals and OTC products effective July 1, 2026, requiring cGMP and DSCSA compliance, relationships with authorized wholesalers including Cencora, Cardinal Health, and Morris & Dickson, and $5 million commercial general liability coverage. The code shows low recent volume and mixed application—water treatment chemicals and pharmaceutical ingredients operate under different regulatory, pricing, and distribution models within the same nominal commodity grouping.